The Board of Directors at their meeting held today viz. Monday 7th February 2022 considered the following: -
1. Approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2021. 2. Approved seeking consent of shareholders by way of Postal Ballot on the following:
a) To consider and approve the modifications in CSTL Employee Stock Option Scheme 2021 b) To ratify the CSTL Employee Stock Option Scheme 2021 c) To approve continuation of employment of Mr. Ashok R. Boob MD consequent to him attaining the age of 70 years w.e.f. 2nd March 2022. d) To approve re-appointment of Mr. Ashok R. Boob as MD for further term of 5 years w.e.f. from 28th July 2022 e) To approve payment of aggregate annual remuneration in excess of 5% of net profits of the Company in a year which includes Fixed Remuneration and 4% Performance Bonus collectively to all the Executive Directors who are promoters till the expiry of their respective terms.